Product NDC: | 68025-058 |
Proprietary Name: | Zonatuss |
Non Proprietary Name: | benzonatate |
Active Ingredient(s): | 150 mg/1 & nbsp; benzonatate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68025-058 |
Labeler Name: | Vertical Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040851 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111101 |
Package NDC: | 68025-058-01 |
Package Description: | 1 CAPSULE in 1 POUCH (68025-058-01) |
NDC Code | 68025-058-01 |
Proprietary Name | Zonatuss |
Package Description | 1 CAPSULE in 1 POUCH (68025-058-01) |
Product NDC | 68025-058 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | benzonatate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20111101 |
Marketing Category Name | ANDA |
Labeler Name | Vertical Pharmaceuticals, Inc. |
Substance Name | BENZONATATE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |